C3G
Immunology·MeSH: Glomerulonephritis, Membranoproliferative
6 drugs in development·4 companies·7 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Iptacopan | Novartis AG (NVS) |
Phase 2(3)
Preclinical(1)
Phase 4(1)
| Drug | Company |
|---|---|
| Avacopan | AMGEN INC (AMGN) |
Compare drugs
Frequently asked questions
How many drugs are in development for C3G?
BioSniper tracks 6 drugs in development for C3G across 4 companies.
How many clinical trials target C3G?
There are 7 clinical trials targeting C3G tracked by BioSniper.
Deep-dive into C3G
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis